2017
DOI: 10.1016/j.poly.2016.12.026
|View full text |Cite
|
Sign up to set email alerts
|

An unusual asymmetric pseudomacrocyclic free base ligand and nickel(II) chelate: X-ray crystallographic and DFT studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 35 publications
0
7
0
Order By: Relevance
“…[4][5][6] Such ligands stabilize metal ions in a range of oxidation states. [7] Examples include structurally characterized Co II/III , [8][9][10][11] Rh I/III , [12][13][14][15] Ir III , [16,17] Ni II , [18][19][20] Pd II , [20][21][22] Pt II , [23][24][25] Cu II , [26][27][28][29] Ag I , [30] and Au III complexes. [31] While pyrrole compounds are key building blocks for organic pharmaceuticals, [32] for example, Tolmetin, [33] Sunitinib, [34] and Glimepiride, [35] studies over the last two decades suggest that pyrrole-imine metal chelates exhibit significant medicinal potential.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[4][5][6] Such ligands stabilize metal ions in a range of oxidation states. [7] Examples include structurally characterized Co II/III , [8][9][10][11] Rh I/III , [12][13][14][15] Ir III , [16,17] Ni II , [18][19][20] Pd II , [20][21][22] Pt II , [23][24][25] Cu II , [26][27][28][29] Ag I , [30] and Au III complexes. [31] While pyrrole compounds are key building blocks for organic pharmaceuticals, [32] for example, Tolmetin, [33] Sunitinib, [34] and Glimepiride, [35] studies over the last two decades suggest that pyrrole-imine metal chelates exhibit significant medicinal potential.…”
Section: Introductionmentioning
confidence: 99%
“…Such ligands stabilize metal ions in a range of oxidation states [7] . Examples include structurally characterized Co II/III , [8–11] Rh I/III , [12–15] Ir III , [16,17] Ni II , [18–20] Pd II , [20–22] Pt II , [23–25] Cu II , [26–29] Ag I , [30] and Au III complexes [31] …”
Section: Introductionmentioning
confidence: 99%
“…[4][5][6] Such ligands stabilize metal ions in a range of oxidation states. [7] Examples include structurally characterized Co II/III , [8][9][10][11] Rh I/III , [12][13][14][15] Ir III , [16,17] Ni II , [18][19][20] Pd II , [20][21][22] Pt II , [23][24][25] Cu II , [26][27][28][29] Ag I , [30] and Au III complexes. [31] While pyrrole compounds are key building blocks for organic pharmaceuticals, [32] e.g., Tolmetin, [33] Sunitini, [34] and Glimepiri, [35] studies over the last two decades suggest that pyrrole-imine metal chelates exhibit significant medicinal potential.…”
Section: Introductionmentioning
confidence: 99%
“…3 Upon reaction with suitable metal ions, deprotonation of the pyrrole nitrogen occurs. Pyrrole-imine chelating agents are therefore strong σ-donor ligands with π-bonding character that dextrously stabilize metal ions in both low and high oxidation states, including Ni(II), [4][5][6] Pd(II), [6][7][8] Pt(II), [9][10][11] Cu(II), [12][13][14][15] Ag(I), 16 and Au(III). 17 Pt(II) complexes are among the most widely studied metal complexes in medicine.…”
Section: Introductionmentioning
confidence: 99%